Figure 1: Western Blot - Anti-eIF2 alpha Antibody (A95082)
Western blot analysis of lysates from rat lung using Anti-eIF2 alpha Antibody. The right hand lane represents a negative control, where the antibody is blocked by the immunising peptide.
Immunohistochemical analysis of paraffin-embedded human breast carcinoma tissue using Anti-eIF2 alpha Antibody. The right hand panel represents a negative control, where the antibody was pre-incubated with the immunising peptide.
Figure 3: Western Blot - Anti-eIF2 alpha Antibody (A95082)
Western blot analysis of various cells using Anti-eIF2 alpha Antibody at 1:1,000 (4°C overnight). Goat Anti-Rabbit IgG (IRDye 800) was used as a secondary at 1:5,000 (25°C, 1 hour).
Immunohistochemical analysis of paraffin-embedded human uterus tissue using Anti-eIF2 alpha Antibody at 1:200 (4°C overnight). Negative control was secondary antibody only.
Immunohistochemical analysis of paraffin-embedded human uterus cancer tissue using Anti-eIF2 alpha Antibody at 1:200 (4°C overnight). Negative control was secondary antibody only.
Immunofluorescence analysis of rat kidney tissue using Anti-eIF2 alpha Antibody (red) at 1:200 (4°C overnight). Cy3 labelled secondary antibody was used at 1:300 (RT 50min). Panel A: Target. Panel B: DAPI. Panel C: Merge.
Immunofluorescence analysis of human liver tissue using Anti-eIF2 alpha Antibody (red) at 1:200 (4°C overnight). Cy3 labelled secondary antibody was used at 1:300 (RT 50min). Panel A: Target. Panel B: DAPI. Panel C: Merge.
